BioSpace News Archive

Drug Development

NIH Believes Common Diuretic Drug Bumetanide Could Lower Risk of Alzheimer’s

The NIH revealed that bumetanide, a drug typically used as a diuretic, maybe a potential treatment for those genetically at risk for Alzheimer’s. Know more about it here.

October 12, 2021
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Late in the Game, CureVac Lays Down COVID Vaccine for a Better Hand

Teamed up with pharma giant GlaxoSmithKline, CureVac is now focusing on a more promising target – second-generation mRNA vaccines.

October 12, 2021
·
2 min read
·
Kate Goodwin
Pharm Country

New Evidence Suggests COVID-19 Vaccines Might Mitigate Long COVID

Evidence is emerging that not only can COVID-19 vaccines help to prevent the condition, but they could serve as a form of “rescue” for those already stricken with it.

October 12, 2021
·
3 min read
·
Heather McKenzie
Business

Another Top J&J Exec Will Make His Exit at End of Year

Two months after J&J CEO Alex Gorsky announced plans to step down, Chief Scientific Officer Paul Stoffels will retire from the life sciences giant at the end of the year.

October 12, 2021
·
4 min read
·
Alex Keown
Deals

GSK Consumer Health Business Has a Slew of Potential Suitors

GSK shares are climbing in premarket trading on rumors that the company’s consumer health business it intends to spin off into a separate company next year is attracting interest from venture capitalists.

October 12, 2021
·
2 min read
·
Alex Keown
Pharm Country

Research Shows that Vaccine Responses are Not One Size Fits All

Population demographics appear to play a crucial role in the development of immunity via vaccination.

October 12, 2021
·
7 min read
·
Sreetama Dutt
Business

Companies Enter Licensing Agreements to Expand Gene Therapy Programs

Takeda entered into a licensing pact with Poseida, Spark entered into a licensing agreement with CombiGene AB, while BridgeBio Pharma announced plans for its second annual R&D Day.

October 12, 2021
·
3 min read
·
Alex Keown
Genetown

Dana-Farber Adjusts Policy In Light of Conflict of Interest Accusations

This followed a report that found that some trustees had, perhaps, taken advantage of this close connection with startups and research programs for their financial gain.

October 12, 2021
·
2 min read
·
Vanessa Doctor, RN
Policy

Pfizer-BioNTech Lead Globally with COVID-19 Vaccine

Although there are many effective and safe COVID-19 vaccines around the world, the preferred vaccine is the Pfizer-BioNTech vaccine. For that and more stories, read on.

October 12, 2021
·
3 min read
·
Mark Terry
Bio NC

vTv Drug Candidate Lowers Blood Sugar Without Increasing DKA Risk

The positive results from a mechanistic study of TTP399 in type 1 diabetes patients suggest that the drug can lower blood glucose without increasing the risk of DKA.

October 12, 2021
·
3 min read
·
Mark Terry